Avalon BioVentures
About
Avalon BioVentures Avalon BioVentures has been driving life sciences innovation from San Diego for over 40 years, managing a $135M fund exclusively for early-stage biotech startups. The exits tell the story: $4B+ generated across investments including Aratana (IPO), Synthorx (acquired by Sanofi), Janux (IPO), and Nerio (acquired by Boehringer Ingelheim for $1.3B). Across the broader Avalon Ventures platform, there have been 255 total investments and 63 portfolio exits. The incubator model is wha
Industries
Stage focus
Pre-SeedSeed
Geography
US
Notable investments
- Janux Therapeutics
- Aratana Therapeutics
- Synthorx
- Nerio Therapeutics
Raising from Avalon BioVentures?
I've worked with founders across the industrial stack. If Avalon BioVentures is on your list, I can help you map the introduction path, sharpen the narrative, and run a tight process.
Talk to Dan